189 related articles for article (PubMed ID: 31917043)
1. Subcapsular Injection of Ultrasonic Contrast Agent Distinguishes between Benign and Malignant Lymph Node Lesions Exhibiting Homogeneous Enhancement in Intravenous Contrast-Enhanced Ultrasound Images.
Liu SR; Liu C; Jing HM; Miao LY; Cui LG; Qian LX; Tan S
Ultrasound Med Biol; 2020 Mar; 46(3):582-588. PubMed ID: 31917043
[TBL] [Abstract][Full Text] [Related]
2. The role of CEUS in characterization of superficial lymph nodes: a single center prospective study.
de Stefano G; Scognamiglio U; Di Martino F; Parrella R; Scarano F; Signoriello G; Farella N
Oncotarget; 2016 Aug; 7(32):52416-52422. PubMed ID: 27191746
[TBL] [Abstract][Full Text] [Related]
3. Contrast-enhanced ultrasound (CEUS) facilitated US in detecting lateral neck lymph node metastasis of thyroid cancer patients: diagnosis value and enhancement patterns of malignant lymph nodes.
Xiang D; Hong Y; Zhang B; Huang P; Li G; Wang P; Li Z
Eur Radiol; 2014 Oct; 24(10):2513-9. PubMed ID: 25005826
[TBL] [Abstract][Full Text] [Related]
4. Value of Shear Wave Elastography Versus Contrast-Enhanced Sonography for Differentiating Benign and Malignant Superficial Lymphadenopathy Unexplained by Conventional Sonography.
Tan S; Miao LY; Cui LG; Sun PF; Qian LX
J Ultrasound Med; 2017 Jan; 36(1):189-199. PubMed ID: 27925679
[TBL] [Abstract][Full Text] [Related]
5. Combination of Lymphatic and Intravenous Contrast-Enhanced Ultrasound for Evaluation of Cervical Lymph Node Metastasis from Papillary Thyroid Carcinoma: A Preliminary Study.
Wei Y; Yu MA; Niu Y; Hao Y; Di JX; Zhao ZL; Cao XJ; Peng LL; Li Y
Ultrasound Med Biol; 2021 Feb; 47(2):252-260. PubMed ID: 33158634
[TBL] [Abstract][Full Text] [Related]
6. Value of Contrast-Enhanced Ultrasound for Evaluation of Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma.
Fang F; Gong Y; Liao L; Ye F; Zuo Z; Li X; Zhang Q; Tang K; Xu Y; Zhang R; Chen S; Niu C
Front Endocrinol (Lausanne); 2022; 13():812475. PubMed ID: 35185795
[TBL] [Abstract][Full Text] [Related]
7. The place of CEUS in distinguishing benign from malignant cervical lymph nodes: a prospective study.
Poanta L; Serban O; Pascu I; Pop S; Cosgarea M; Fodor D
Med Ultrason; 2014 Mar; 16(1):7-14. PubMed ID: 24567918
[TBL] [Abstract][Full Text] [Related]
8. Potential use of contrast-enhanced ultrasound (CEUS) in the detection of metastatic superficial lymph nodes in melanoma patients.
Rubaltelli L; Beltrame V; Scagliori E; Bezzon E; Frigo AC; Rastrelli M; Stramare R
Ultraschall Med; 2014 Feb; 35(1):67-71. PubMed ID: 23860858
[TBL] [Abstract][Full Text] [Related]
9. Clinical application of contrast-enhanced ultrasonography in diagnosis of superficial lymphadenopathy.
Yu M; Liu Q; Song HP; Han ZH; Su HL; He GB; Zhou XD
J Ultrasound Med; 2010 May; 29(5):735-40. PubMed ID: 20427785
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of contrast-enhanced ultrasound in the differential diagnosis of benign and malignant lateral cervical lymph nodes].
Liu NX; Tang LN; Wang YQ; Huang WQ
Zhonghua Yi Xue Za Zhi; 2020 Aug; 100(29):2258-2262. PubMed ID: 32746594
[No Abstract] [Full Text] [Related]
11. Application of multimodal ultrasonography for differentiating benign and malignant cervical lymphadenopathy.
Yang JR; Song Y; Jia YL; Ruan LT
Jpn J Radiol; 2021 Oct; 39(10):938-945. PubMed ID: 33970452
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic Value of Arrival Time Parametric Imaging Using Contrast-Enhanced Ultrasonography in Superficial Enlarged Lymph Nodes.
Yin SS; Cui QL; Fan ZH; Yang W; Yan K
J Ultrasound Med; 2019 May; 38(5):1287-1298. PubMed ID: 30208240
[TBL] [Abstract][Full Text] [Related]
13. Utility of quantitative contrast-enhanced ultrasound for the prediction of lymph node metastasis in patients with papillary thyroid carcinoma.
Luo ZY; Hong YR; Yan CX; Wang Y; Ye Q; Huang P
Clin Hemorheol Microcirc; 2022; 80(1):37-48. PubMed ID: 33252064
[TBL] [Abstract][Full Text] [Related]
14. Value of Qualitative and Quantitative Contrast-Enhanced Ultrasound Analysis in Preoperative Diagnosis of Cervical Lymph Node Metastasis From Papillary Thyroid Carcinoma.
Chen L; Chen L; Liu J; Wang B; Zhang H
J Ultrasound Med; 2020 Jan; 39(1):73-81. PubMed ID: 31222782
[TBL] [Abstract][Full Text] [Related]
15. Contrast-enhanced US with Perfluorobutane to Diagnose Small Lateral Cervical Lymph Node Metastases of Papillary Thyroid Carcinoma.
Xiao L; Zhou J; Tan W; Liu Y; Zheng H; Wang G; Zheng W; Pei X; Yang A; Liu L
Radiology; 2023 May; 307(4):e221465. PubMed ID: 37014242
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of lymph node perfusion using continuous mode harmonic ultrasonography with a second-generation contrast agent.
Rubaltelli L; Khadivi Y; Tregnaghi A; Stramare R; Ferro F; Borsato S; Fiocco U; Adami F; Rossi CR
J Ultrasound Med; 2004 Jun; 23(6):829-36. PubMed ID: 15244307
[TBL] [Abstract][Full Text] [Related]
17. Comparison of microvascular flow imaging and contrast-enhanced ultrasound for blood flow analysis of cervical lymph node lesions.
Wang T; Xu M; Xu C; Wu Y; Dong X
Clin Hemorheol Microcirc; 2023; 85(3):249-259. PubMed ID: 37694358
[TBL] [Abstract][Full Text] [Related]
18. [Value of Trans-lymphatic Contrast-enhanced Ultrasound in the Diagnosis of Cervical Lymph Node Metastasis of Thyroid Cancer].
Zhang Y; Ma B; Zhao JH; Zhang Y; Zhu JN; Zhao P; Luo YK
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2021 Jun; 43(3):338-342. PubMed ID: 34238408
[TBL] [Abstract][Full Text] [Related]
19. [The perfusion pattern of lymphadenopathy in contrast-enhanced ultrasonograph. under different reference conditions ].
Jin Y; Peng YL; Qiu L; Ma BY; Zhao HN; Luo HH; He YS; Yang P
Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 Nov; 45(6):1005-9. PubMed ID: 25571734
[TBL] [Abstract][Full Text] [Related]
20. Application of Contrast-Enhanced Ultrasound (CEUS) in Lymphomatous Lymph Nodes: A Comparison between PET/CT and Contrast-Enhanced CT.
Ma X; Ling W; Xia F; Zhang Y; Zhu C; He J
Contrast Media Mol Imaging; 2019; 2019():5709698. PubMed ID: 30809108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
